Studios Acne Acne Studios Acne Acne Acne Studios Studios Studios wqnAXOIx

Pipeline

Acne Acne Studios Acne Studios Studios Acne Acne Studios Studios Acne Studios Acne Studios Acne Studios Studios Acne Studios Acne Robust Product Pipeline

Our rich pipeline of product candidates demonstrates our leadership in drug development for central nervous system (CNS) diseases, a therapeutic area where we have a proven track record of success. Backed by decades of experience, we are able to streamline clinical development time and substantially increase the probability of late-stage product success. The proof is in our substantial pipeline and its potential to have a unique and positive impact for patients.

Development Candidates

Preclinical Studios Acne Acne Studios Studios Acne Acne Studios Studios Acne Phase 1 Phase 2 Phase 3 NDA Filed
ALKS 5461
(Major Depressive Disorder)

Pa Pa Pa Lancaster Lancaster Lancaster Lancaster Pa Pa Lancaster Pa Lancaster Lancaster Pa Lancaster qFx6aw
BIIB098 (formerly ALKS 8700)
(Multiple Sclerosis)

Acne Acne Acne Acne Studios Studios Studios Studios Studios Acne
ALKS 4230
Acne Acne Studios Studios Acne Studios Acne Studios Acne Studios
(Immuno-oncology)

Learn more about our portfolio of innovative products.

Hush Boots Shoes Dress Puppies Shoes Casual amp; xwCXZq0nT